Ganji Purnachandra Nagaraju, MSc, PhD

Instructor, Hematology & Medical Oncology

Emory University School of Medicine

Office: Winship Cancer Institute of Emory University

Phone: (404) 778-3558

Fax: (404) 778-5520



Dr. G. Purnachandra Nagaraju received his MSc and his PhD, both in Biotechnology, from Sri Venkateswara University in Tirupati, Andhra Pradesh, India.

Dr. Nagaraju is a member of the Discovery and Developmental Therapeutics Research Program at Winship Cancer Institute. He also holds memberships with the Association of Scientists of Indian Origin in America, the Society for Integrative and Comparative Biology, the Science Advisory Board, The RNA Society and the American Association of Cancer Research.

Full Clinical Bio >>


Dr. Nagaraju's work mainly focuses on basic as well as translational cancer research. As a leading researcher in the cancer field, he is currently investigating the role of HSP-90 inhibitors, curcumin and its analogues in advanced cancers. His research focuses on translational projects related to gastrointestinal malignancies, specifically pancreatic and colorectal cancer, to bring observations derived from in vitro and in vivo models of cancer cell growth to the translational level. Dr. Nagaraju collaborates closely with clinicians in studies that target the HSP90, SPARC and DNMT-1 cell signaling pathways in pancreatic as well as colorectal cancer.


Dr. Nagaraju has published over 40 research papers in several prestigious peer-reviewed journals and presented over 30 abstracts in various conferences. He was also given the Junior Scientist award by the ASIOA. He serves as an editorial board member and a reviewer of several internationally recognized academic journals.